Description
Semax | Product Description
Semax | Introduction
Semax is cataloged here under the following research classification: Synthetic heptapeptide analogue of the ACTH(4-10) fragment. This catalog material is offered strictly for controlled laboratory research. It is not intended for diagnostic, therapeutic, human, or veterinary use.
- Neurotrophin-expression models
- Peptide-binding studies
- Neural gene-expression research
At a glance: Synthetic heptapeptide analogue of the ACTH(4-10) fragment · 5 MG labeled strengths · Batch-specific documentation
Semax | Molecular Identity & Composition
| Material name | Semax |
|---|---|
| Research classification | Synthetic heptapeptide analogue of the ACTH(4-10) fragment |
| Research context | Neurotrophin and neural signaling systems examined in preclinical models |
| Labeled quantity | 5 mg |
| SKU | NTR-SEMAX-5MG |
| Physical form and storage | Confirm against the specific batch record and packaging before handling |
| Purity and identity | Batch-specific results only; review the Third-Party COA tab when an approved record is available |
Semax | Available Strengths
Select the labeled strength required for the approved laboratory protocol:
- 5 MG
Each strength retains its own inventory stage and batch-documentation relationship.
Ntegrity Quality & Documentation
Ntegrity Labs treats analytical evidence as batch-specific. A product-level statement does not replace the underlying laboratory report. When approved documentation is available, the testing tab identifies the relevant material, batch, laboratory, methods, test date, and reported results.
- No purity claim is applied across unrelated batches.
- Third-party and group-buy reports retain their original laboratory and customer provenance.
- A report is published only after its product and batch relationship has been reviewed.
Category Overview | Neuroactive Peptide Research Materials
This category includes synthetic peptides investigated in neural signaling, gene-expression, and neurotrophin-response models.
Category placement describes research context only. It is not a statement of clinical performance, safety, or intended therapeutic use.
Semax | Research Context & Applications
Semax is described as the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro and an analogue of ACTH(4-10). Primary rat studies examine binding and changes in BDNF or NGF expression. These findings do not establish clinical performance for this material.
Published studies describe the referenced research molecule or catalog context. They do not verify the identity of an untested batch or establish an intended use for the Ntegrity Labs material on this page.
Research Use Disclaimer
This material is intended exclusively for laboratory research and analytical work. It is not for human or veterinary use and is not intended for diagnosis, treatment, cure, mitigation, or prevention of disease. Purchasers are responsible for lawful acquisition, qualified handling, appropriate storage, and use within suitable research facilities.
